Form 4: Oscar Health Director David Plouffe Receives Deferred Stock Units

Director David Plouffe received 1,734 deferred stock units of Oscar Health, Inc. in lieu of cash retainer payments for board service.

Summary

• On April 10, 2025, David Plouffe, a director of Oscar Health, Inc., acquired 1,734 deferred stock units.
• These units were granted in lieu of cash retainer payments for his service on the Issuer's board of directors.
• The price used to calculate the number of deferred stock units was $12.25, representing the closing price of Oscar Health's Class A common stock on April 10, 2025.
• The deferred stock units will be settled for cash or shares of Class A common stock, at the Issuer's discretion, within 45 days of termination of service, a change in control, death, or disability.
• The deferred stock units are 100% vested on the grant date.

Sentiment

Score: 7

Explanation: The document reflects a neutral event (director compensation) with positive implications for aligning director interests with company performance.

Positives

• The director's compensation structure aligns his interests with the long-term performance of the company through deferred stock units.
• The immediate vesting of the deferred stock units provides an incentive for continued service.

Future Outlook

The deferred stock units will be settled for cash or shares of Class A common stock, in the Issuer's discretion, within 45 days of the first to occur of (i) termination of service; (ii) a change in control; (iii) death; or (iv) disability.

Industry Context

This Form 4 filing is a routine disclosure related to insider compensation and holdings, common in the healthcare and insurance industries where stock-based compensation is prevalent.

Comparison to Industry Standards

• Stock-based compensation for directors is a common practice across publicly traded companies, including those in the healthcare sector like UnitedHealth Group (UNH) and Anthem (ANTM).
• The vesting schedules and settlement terms are generally aligned with industry norms to incentivize long-term value creation and retention.
• The amount of deferred stock units granted is likely determined based on the company's compensation policies and the director's role and responsibilities, similar to practices at companies like Humana (HUM) and Cigna (CI).

Stakeholder Impact

• Shareholders may view this as a positive sign that the director's interests are aligned with the company's long-term success.
• Employees may see this as a standard practice for director compensation.

Key Dates

Keywords

Form 4, David Plouffe, Oscar Health, OSCR, Deferred Stock Units, Director Compensation, Beneficial Ownership, Securities Exchange Act